The grey market premium (GMP) of stainless steel maker Rajputana Stainless remained muted on the final day of subscription of its initial public offering (IPO). Valued at ₹254.98 crore, the issue, ...
The Innovision IPO, which opened for subscription on March 10, was initially set to close on March 12. However, the company has revised the price band to ₹494-519 per share from the earlier ₹521-548 ...
Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company developing intranasal administrated solutions, today announced the successful production of a ...
Amerigo Scientific launched a comprehensive portfolio of GMP-grade proteins tailored to accelerate the development and ...
ViruSure, an Asahi Kasei company and global leader in pathogen safety testing for biopharmaceuticals, today announced the launch of the world’s first GMP-validated adventitious viral agent (AVA) ...
PDA Publishes Revised Technical Report No. 56: A Clear, Phase Appropriate Roadmap for GMP Compliant Development of Biological Drug Substances Technical Report No. 56 (Revised 2026) outlines a ...
The study of oral microbiome is broadening the debate on dental health and prevention. ProvaDent appears in the context of ...
Foreign facilities failed FDA GMP inspections at up to 1.8x the U.S. rate. Journal of Pharmaceutical Innovation study ...
The Hyundai Elexio medium electric SUV and the Kia EV5 are mechanically-related, but Hyundai ...
Steel Horse Rides on MSN
Four electric SUVs deliver real driving thrills without burning gas
Not long ago, the phrase “performance electric SUV” would have drawn blank stares at a […] ...
Kivo reports that the journey of prescription drugs involves extensive research, clinical trials, regulatory reviews, and ...
Through its investment in PsyLabs, Psyence BioMed has secured: A licensed, owned, and debt-free production operation. Source-level ibogaine supply. Natural psilocybin supply. GMP-compliant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results